Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodelingCarla Danussi, Jason T. Huse, Promita Bose et al.|Nature Communications|2018Cited by 90
TMEM43/LUMA is a key signaling component mediating EGFR-induced NF-κB activation and tumor progressionChangying Jiang, Xin Lin, Yifan Zhu et al.|Oncogene|2016Cited by 52
Serial multiomics uncovers anti-glioblastoma responses not evident by routine clinical analysesAlexander Ling, Patrick Y. Wen, Jennifer Gantchev et al.|Science Translational Medicine|2025Cited by 12
Investigative needle core biopsies for multi-omics in GlioblastomaKenny K.H. Yu, Nathalie Y.R. Agar, Sreyashi Basu et al.|medRxiv|2023Cited by 6